October 11, 2018
Research Assistant Andres Berdeja works at one of the Ionis labs in Carlsbad. File photo by Jamie Scott Lytle
Stories this photo appears in:
Ionis Pharmaceuticals’ drug for a rare genetic disorder recently gained regulatory approval, a relief to investors worried about a denial, and pitting the company against Alnylam Pharmaceuticals.